|
"A comprehensive, collaborative elections resource."
|
After meeting with pharma lobbyists, Trump drops promise to negotiate drug prices
|
Parent(s) |
Issue
|
Contributor | RP |
Last Edited | RP Feb 01, 2017 01:55pm |
Logged |
0
|
Category | General |
Author | Matthew Yglesias |
News Date | Tuesday, January 31, 2017 04:50:00 PM UTC0:0 |
Description | A lot happened in the 2016 campaign, but one of the things Donald Trump did to win the election was shift to the left on a number of key issues — promising to avoid cuts in Social Security and Medicare benefits and adopting a longstanding Democratic pledge to let Medicare negotiate bulk discounts in the price it pays for prescription drugs.
Today, after a meeting with pharmaceutical industry lobbyists and executives, he abandoned that pledge, referring to an idea he supported as recently as three weeks ago as a form of “price fixing” that would hurt “smaller, younger companies.” Instead of getting tough, Trump’s new plan is that he’s “going to be lowering taxes” and “getting rid of regulations.” |
Share |
|
2¢
|
|
Article | Read Full Article |
|
Date |
Category |
Headline |
Article |
Contributor |
|
|